IMBDX Inc is a Korea-based company principally engaged in the provision of laboratory analysis services. The Company is principally engaged in the provision of laboratory analysis services such as clinical diagnosis services and genetic analysis services based on liquid biopsy technology. In addition, the Company is also engaged in the development, manufacture and sale of diagnostic products. The Company sells its products in domestic and overseas markets.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
30/26/30	₩2,395.00	0.00%	8,868
29/26/29	₩2,395.00	-3.23%	25,245
28/26/28	₩2,475.00	-1.39%	14,271
27/26/27	₩2,510.00	+1.41%	11,376
26/26/26	₩2,475.00	-0.80%	15,265

End-of-day quote Korea S.E.

More quotes

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - IMB Dx, Inc.

Company calendar

End-of-day quote Korea S.E. 30/10/2026			5-day change	1st Jan Change
2,395.00 ^KRW	0.00%		-4.01%	-75.78%

Market Cap	3.36TCr 2.52Cr 2.25Cr 2.07Cr 1.88Cr 3.51Cr 239Cr 3.58Cr 25Cr 9.93Cr 125.72Cr 9.45Cr 9.25Cr 396.48Cr	P/E 2024	-14.9x	P/E 2025	-17.5x
Enterprise Value	1.33TCr 1Cr 89.56L 82.38L 74.65L 1.4Cr 95Cr 1.42Cr 9.82Cr 3.94Cr 50Cr 3.75Cr 3.67Cr 157.52Cr	EV / Sales 2024	35.6x	EV / Sales 2025	22.2x
Free-Float	53.98%	Yield 2024 *	-	Yield 2025	-

1 week	-4.01%
Current month	-17.84%
1 month	-17.84%
3 months	-10.97%
6 months	-65.59%
Current year	-75.78%

1 week	2,300	2,550
1 month	2,300	3,060
Current year	1,910	11,260
1 year	1,910	12,950
3 years	1,910	40,550
5 years	1,910	40,550
10 years	1,910	40,550

Manager	Title	Age	Since
Tae-Yu Kim CEO	Chief Executive Officer	65	05/07/2018
Jin-Won Joo DFI	Director of Finance/CFO	52	-
Yong-Jun Cha CTO	Chief Tech/Sci/R&D Officer	-	-

IMB Dx, Inc. Share Price

Stocks

A461030

KR7461030009

Biotechnology & Medical Research

Valuation: IMB Dx, Inc.

Chart: IMB Dx, Inc.

Latest news: IMB Dx, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: IMB Dx, Inc.

Latest insider transactions

Bio Diagnostics & Testing

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

Director	Title	Age	Since
Tae-Yu Kim BRD	Director/Board Member	65	05/07/2018
Hwang-Pil Kim BRD	Director/Board Member	51	-
Ki-Won Yoon BRD	Director/Board Member	66	29/03/2023

Date	Insider	Type	Main position	Quantity	% Market Cap.
09/04/24	Hwang-Pil Kim	Free	Director	18,925	-
09/04/24	Soo-Yeon Kim	Free	Director	3,775	-
09/04/24	Tae-Yu Kim	Free	Founder	18,75,000	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IMB DX, INC.	0.00%	-4.01%	-77.62%	-	2.52Cr
WUXI APPTEC CO., LTD.	-0.62%	-1.87%	+46.31%	+56.99%	6.38TCr
ARGENX SE	+0.35%	+3.20%	+14.92%	+84.55%	5.64TCr
LONZA GROUP AG	+0.53%	+1.96%	+15.37%	+106.81%	5.46TCr
IQVIA HOLDINGS INC.	-2.81%	-4.31%	+23.50%	+50.90%	4.41TCr
BEONE MEDICINES AG	-0.33%	-1.93%	+20.15%	+98.45%	4.21TCr
REVOLUTION MEDICINES, INC.	+0.55%	+2.31%	+224.97%	+942.56%	4.1TCr
GENMAB A/S	+3.27%	+47.96%	+112.67%	+96.48%	3.49TCr
CELLTRION, INC.	+1.22%	-1.44%	+14.89%	+47.15%	3.28TCr
INSMED INCORPORATED	+0.89%	+20.55%	-42.03%	+373.03%	2.47TCr
Average	+0.31%	+6.46%	+35.31%	+206.32%	3.94TCr
Weighted average by Cap.	+0.18%	+5.44%	+48.49%	+186.13%

	2024	2025
Net sales	340.7Cr 25.54L 22.88L 21.04L 19.07L 35.64L 24Cr 36.31L 2.51Cr 1.01Cr 13Cr 95.86L 93.82L 40Cr	532.86Cr 39.95L 35.78L 32.91L 29.82L 55.74L 38Cr 56.79L 3.92Cr 1.58Cr 20Cr 1.5Cr 1.47Cr 63Cr
Net income	-957.67Cr -71.8L -64.31L -59.15L -53.6L -1Cr -68Cr -1.02Cr -7.05Cr -2.83Cr -36Cr -2.69Cr -2.64Cr -113.1Cr	-793.39Cr -59.48L -53.27L -49L -44.4L -83L -56Cr -84.55L -5.84Cr -2.35Cr -30Cr -2.23Cr -2.18Cr -94Cr
Net Debt	-2.81TCr -2.11Cr -1.89Cr -1.74Cr -1.57Cr -2.94Cr -200.19Cr -3Cr -21Cr -8.31Cr -105.31Cr -7.91Cr -7.74Cr -332.1Cr	-2.02TCr -1.52Cr -1.36Cr -1.25Cr -1.13Cr -2.12Cr -144.05Cr -2.16Cr -15Cr -5.98Cr -76Cr -5.69Cr -5.57Cr -238.96Cr